William A. Ricke

Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.

Matrix metalloproteinase (2, 9, and 14) expression, localization, and activity in ovine corpora lutea throughout the estrous cycle.

Analysis of luteal tissue inhibitor of metalloproteinase-1, -2, and -3 during prostaglandin F(2alpha)-induced luteolysis.

Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.

Role of the stromal microenvironment in carcinogenesis of the prostate.

Steroid hormones stimulate human prostate cancer progression and metastasis.

Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.

Steroid hormones and carcinogenesis of the prostate: the role of estrogens.

Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling.

Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist.

Androgen receptor is a tumor suppressor and proliferator in prostate cancer.

Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.

Thrombin expression in prostate: a novel finding.

Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia.

Developmental, cellular and molecular biology of benign prostatic hyperplasia.

LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system.

Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.

Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice.

Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma.

Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.

Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia.

Microfluidic multiculture assay to analyze biomolecular signaling in angiogenesis.

Impact of a folic acid-enriched diet on urinary tract function in mice treated with testosterone and estradiol.

CD147 expression predicts biochemical recurrence after prostatectomy independent of histologic and pathologic features.

SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.

Biomarker discovery in mass spectrometry-based urinary proteomics.

In Utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood.

Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression.

Monohaloacetic acid drinking water disinfection by-products inhibit follicle growth and steroidogenesis in mouse ovarian antral follicles in vitro.

Comparison of Picrosirius Red Staining With Second Harmonic Generation Imaging for the Quantification of Clinically Relevant Collagen Fiber Features in Histopathology Samples.

In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms.

Prostate cancer xenografts and hormone induced prostate carcinogenesis.

Void spot assay procedural optimization and software for rapid and objective quantification of rodent voiding function, including overlapping urine spots.

Endocrine disruptor bisphenol A is implicated in urinary voiding dysfunction in male mice.

Modeling human prostate cancer progression in vitro.

Inflammation, Voiding and Benign Prostatic Hyperplasia Progression.

Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS.

Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation.

Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis.

Quantitative proteomic analysis of a genetically induced prostate inflammation mouse model via custom 4-plex DiLeu isobaric labeling.

Tissue-specific quantification and localization of androgen and estrogen receptors in prostate cancer.

Prostate enlargement and altered urinary function are part of the aging process.

Expression and distribution of PIEZO1 in the mouse urinary tract.

MRI-based method for lower urinary tract dysfunction in adult male mice.

Void sorcerer: an open source, open access framework for mouse uroflowmetry.

Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology: Functional Assessment.